Abstract

BackgroundSubclinical diastolic dysfunction is a precursor for developing heart failure with preserved ejection fraction (HFpEF); yet not all patients progress to HFpEF. Our objective was to evaluate clinical and echocardiographic variables to identify patients who develop HFpEF.MethodsClinical, laboratory, and echocardiographic data were retrospectively collected for 81 patients without HF and 81 matched patients with HFpEF at the time of first documentation of subclinical diastolic dysfunction. Density-based clustering or hierarchical clustering to group patients was based on 65 total variables including 19 categorical and 46 numerical variables. Logistic regression analysis was conducted on the entire study population as well as each individual cluster to identify independent predictors of HFpEF.ResultsUnsupervised clustering identified 3 subgroups which differed in gender composition, severity of cardiac hypertrophy and aortic stenosis, NT-proBNP, percentage of patients who progressed to HFpEF, and timing of disease progression from diastolic dysfunction to HFpEF to death. Clusters that had higher percentages of women had progressively milder cardiac hypertrophy, less severe aortic stenosis, lower NT-proBNP, were diagnosed at an older age with HFpEF, and survived to an older age. Independent predictors of HFpEF for the entire cohort included diabetes, chronic kidney disease, atrial fibrillation, and diuretic use, with additional predictive variables found for each cluster.ConclusionsCluster analysis can identify phenotypically distinct subgroups of patients with diastolic dysfunction. Clusters differ in HFpEF and mortality outcome. In addition, the variables that correlate with and predict HFpEF outcome differ among clusters.

Highlights

  • Subclinical diastolic dysfunction is a precursor for developing heart failure with preserved ejection fraction (HFpEF); yet not all patients progress to HFpEF

  • Patients in Group 1 diagnosed with HFpEF were optimally matched for age, gender, race, and body surface area (BSA) with Group 2 patients who remained in asymptomatic diastolic dysfunction

  • Patients were diagnosed with subclinical diastolic dysfunction at age 70 ± 10 years and of these, those patients who were known to develop HFpEF were diagnosed at age 74 ± 10 years

Read more

Summary

Introduction

Subclinical diastolic dysfunction is a precursor for developing heart failure with preserved ejection fraction (HFpEF); yet not all patients progress to HFpEF. Asymptomatic diastolic dysfunction precedes the development of HFpEF; yet, not all patients with diastolic dysfunction will progress to clinical or symptomatic HFpEF, possibly due to the phenotypic heterogeneity of this population. HFpEF suffers from lack of any standardized therapies that effectively reduce mortality [2, 4–6] and the prevention of HFpEF remains a goal. This highlights the importance of understanding the risk factors associated with progression from diastolic dysfunction to HFpEF, as a path towards improving prognostication of the disease, personalizing therapy, and improving clinical outcomes, namely progression to clinical HFpEF or overall mortality

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.